Team |
Sally Kim, PhD
Sally Kim, PhD

Sally Kim, PhD

Scientist II

Preclinical Development

Sally is focused on developing preclinical studies for therapeutic programs at Life Edit Therapeutics.

She has six years of experience in developing AAV-based gene therapy approaches for neurodevelopmental disorder.

Sally received PhD in Neuroscience from University of North Carolina at Chapel Hill.

Connect with

Visionary science, driven by visionary values.

Our Mission

To rewrite the future by curing disease, making any edit, anywhere.

Our Vision

To pave the way to faster, safer, gene editing therapeutics that cure disease and improve patient lives.

Our Values

We’re guided by curiosity, rigor, and integrity. We believe in discovery and unlimited potential. We care about science and the lives of patients.